Evidence map›Paper›PMID 25269704›Full record

ArticleMucosal immunology2015

A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.

P Holmkvist, K Roepstorff, H Uronen-Hansson, C Sandén, S Gudjonsson, O Patschan, O Grip, J Marsal, A Schmidtchen, L Hornum and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Bystander CD4Experimental & molecular medicine · 2020
    Review
  9. JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. CD4 TFrontiers in immunology · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

P Holmkvist1] Immunology Section, Lund University, Lund, Sweden [2] Biopharmaceuticals Research Unit, Novo Nordisk A/S, Måløv, Denmark.
K RoepstorffBiopharmaceuticals Research Unit, Novo Nordisk A/S, Måløv, Denmark.
H Uronen-HanssonImmunology Section, Lund University, Lund, Sweden.
C SandénUnit of Airway Inflammation and Immunology, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
S GudjonssonDepartment of Urology, Skåne University Hospital, Malmö, Sweden.
O PatschanDepartment of Urology, Skåne University Hospital, Malmö, Sweden.
O GripDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
J MarsalDepartment of Gastroenterology, Skåne University Hospital, Lund, Sweden.
A Schmidtchen1] Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden [2] LKC Medicine, Nanyang Technological University, Singapore, Singapore.
L HornumBiopharmaceuticals Research Unit, Novo Nordisk A/S, Måløv, Denmark.
J S ErjefältUnit of Airway Inflammation and Immunology, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
K HåkanssonBiopharmaceuticals Research Unit, Novo Nordisk A/S, Måløv, Denmark.
W W Agace1] Immunology Section, Lund University, Lund, Sweden [2] Section of Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Frederiksberg, Denmark.
Lund University · SENovo Nordisk (Denmark) · DKSkåne University Hospital · SENanyang Technological University · SGTechnical University of Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosal tissues contain large numbers of memory CD4(+) T cells that, through T-cell receptor-dependent interactions with antigen-presenting cells, are believed to have a key role in barrier defense and maintenance of tissue integrity. Here we identify a major subset of memory CD4(+) T cells at barrier surfaces that coexpress interleukin-18 receptor alpha (IL-18Rα) and death receptor-3 (DR3), and display innate lymphocyte functionality. The cytokines IL-15 or the DR3 ligand tumor necrosis factor (TNF)-like cytokine 1A (TL1a) induced memory IL-18Rα(+)DR3(+)CD4(+) T cells to produce interferon-γ, TNF-α, IL-6, IL-5, IL-13, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-22 in the presence of IL-12/IL-18. TL1a synergized with IL-15 to enhance this response, while suppressing IL-15-induced IL-10 production. TL1a- and IL-15-mediated cytokine induction required the presence of IL-18, whereas induction of IL-5, IL-13, GM-CSF, and IL-22 was IL-12 independent. IL-18Rα(+)DR3(+)CD4(+) T cells with similar functionality were present in human skin, nasal polyps, and, in particular, the intestine, where in chronic inflammation they localized with IL-18-producing cells in lymphoid aggregates. Collectively, these results suggest that human memory IL-18Rα(+)DR3(+) CD4(+) T cells may contribute to antigen-independent innate responses at barrier surfaces.

Indexed as

Immunity, InnateCD4-Positive T-LymphocytesCrohn DiseaseEpithelial CellsGene Expression RegulationGranulocyte-Macrophage Colony-Stimulating FactorHumansImmunity, MucosalImmunologic MemoryInterferon-gammaInterleukin-13Interleukin-15Interleukin-22Interleukin-5Interleukin-6InterleukinsGranulocyte-Macrophage Colony-Stimulating FactorIL13 protein, humanIL15 protein, humanIL5 protein, humanIL6 protein, humanInterferon-gammaInterleukin-13Interleukin-15Interleukin-22Interleukin-5Interleukin-6InterleukinsReceptors, Interleukin-18Receptors, Tumor Necrosis Factor, Member 25TNFRSF25 protein, humanTNFSF15 protein, humanTumor Necrosis Factor-alphaTumor Necrosis Factor Ligand Superfamily Member 15

Identifiers

PMID25269704
PMCPMC4424383
OpenAlexW2021419754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.